Dijk, Frederike http://orcid.org/0000-0003-3970-6601
Veenstra, Veronique L.
Soer, Eline C.
Dings, Mark P. G. http://orcid.org/0000-0001-8509-0006
Zhao, Lan
Halfwerk, Johannes B.
Hooijer, Gerrit K.
Damhofer, Helene
Marzano, Marco
Steins, Anne
Waasdorp, Cynthia
Busch, Olivier R.
Besselink, Marc G.
Tol, Johanna A.
Welling, Lieke
van Rijssen, Lennart B.
Klompmaker, Sjors
Wilmink, Hanneke W.
van Laarhoven, Hanneke W.
Medema, Jan Paul
Vermeulen, Louis
van Hooff, Sander R.
Koster, Jan
Verheij, Joanne
van de Vijver, Marc J.
Wang, Xin http://orcid.org/0000-0002-5122-2418
Bijlsma, Maarten F.
Funding for this research was provided by:
Research Grants Council, University Grants Committee (CityU 11102317)
Article History
Received: 17 July 2019
Accepted: 17 December 2019
First Online: 15 January 2020
Competing interests
: The authors declare no competing interests. H.L. has acted as a consultant for BMS, Eli Lilly and Company, and Nordic Pharma Group, and has received unrestricted research grants from Bayer Schering Pharma AG, BMS, Celgene, Eli Lilly and Company, Nordic Pharma Group, Philips, and Roche Pharmaceuticals. M.F.B. has received research funding from Celgene, and has acted as a consultant for Servier. None of these were involved in drafting of the manuscript.